CND Life Sciences
CND Life Sciences is a diagnostics company developing innovative tools for the detection of neurodegenerative diseases. Their flagship product, the Syn-One Test®, is the first commercially available skin-based diagnostic that visualizes and quantifies abnormal alpha-synuclein, a key marker of synucleinopathies.
Funding Round: Series A3
Funding Amount: $13.5M
Date: 14-May-2025
Investors: VILAS Ventures
Markets: Healthtech, Diagnostics, Biotechnology, Health Diagnostics, Life Science, Medical
HQ: Scottsdale, Arizona, United States
Founded: 2017
Website: https://cndlifesciences.com/
LinkedIn: https://www.linkedin.com/company/cnd-life-sciences
Crunchbase: https://www.crunchbase.com/organization/cnd-life-sciences
Leave a Comment
Comments
No comments yet.